"Enhancement of Tumor Cell Susceptibility to Tumor-Infiltrating Lymphocytes by Cisplatin."

According to the authors' abstract of an article published in Journal of Cancer Research and Clinical Oncology, "Some means of enhancing the susceptibility of tumor cells to tumor-infiltrating lymphocytes (TIL) are required in adoptive immunotherapy. This study was designed to investigate whether or not tumor cell lysis by TIL was enhanced by treatment of the tumor cells with cisplatin, and also to clarify the mechanism of cisplatin's action on tumor cells. Autologous tumor cells and established cancer cell lines, including KATO-III and MKN-28, were used. Cytotoxic activities of TIL, the surface antigens of tumor cells, conjugation of TIL and tumor cells, and the production of TNF alpha...

Want to see the full article?

• Purchase this article for only $3.00